DYAX CORP
10-Q, EX-27, 2000-11-09
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: DYAX CORP, 10-Q, EX-10.3, 2000-11-09
Next: ACTEL CORP, 4, 2000-11-09



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               SEP-30-2000             SEP-30-1999
<CASH>                                          72,495                  19,152
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    5,220                   3,015
<ALLOWANCES>                                     (129)                   (129)
<INVENTORY>                                      3,174                   2,322
<CURRENT-ASSETS>                                83,377                  24,800
<PP&E>                                           7,176                   5,051
<DEPRECIATION>                                 (3,593)                 (2,749)
<TOTAL-ASSETS>                                  88,459                  30,770
<CURRENT-LIABILITIES>                            8,890                   7,007
<BONDS>                                              0                       0
                                0                       0
                                          0                  57,426
<COMMON>                                           188                      23
<OTHER-SE>                                     140,732                  14,515
<TOTAL-LIABILITY-AND-EQUITY>                    72,358                (34,604)
<SALES>                                         10,291                   8,833
<TOTAL-REVENUES>                                16,560                  11,642
<CGS>                                            4,780                   3,850
<TOTAL-COSTS>                                   28,689                  21,786
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 143                      60
<INCOME-PRETAX>                               (11,218)                 (9,265)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                  (11,218)                 (9,265)
<EPS-BASIC>                                     (2.20)                  (4.99)
<EPS-DILUTED>                                   (2.20)                  (4.99)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission